收肌管阻滞与鞘内吗啡在全膝关节置换术后镇痛与功能恢复中的相对贡献:一项随机对照试验
主要结局为术后第2天计时起立行走测试,三组无差异;联合组在术后12小时静息和运动疼痛评分、静脉患者自控镇痛使用率及术后48小时累积阿片需求量方面显示更优镇痛效果。
要点
- 收肌管阻滞联合100μg鞘内吗啡未改善术后第2天计时起立行走测试及3个月功能结局。
- 联合组术后12小时静息和运动疼痛评分更低,静脉患者自控镇痛使用率更低。
- 联合组术后48小时累积阿片需求量最低,但主要功能结局无差异。
核心结论
- 三组术后第2天计时起立行走测试及其他短期和3个月功能结局无差异。
- 收肌管阻滞联合100μg鞘内吗啡在术后48小时内显示更优镇痛特征,表现为疼痛评分和阿片需求量降低。
研究设计与样本
- 所有患者接受标准化术中局部浸润镇痛和术后口服镇痛药。
主要发现
- 术后第2天计时起立行走测试三组分别为46[36-62]、45[33-61]和52[41-69],P=0.166。
- 术后12小时静息疼痛评分三组分别为4[2-6.3]、4[2.3-6]和3[1-4],P=0.007。
- 术后12小时运动疼痛评分三组分别为6[4-8]、6[3-8]和4[2-6],P=0.002。
- 静脉患者自控镇痛使用率三组分别为42%、34%和20%,P=0.031。
- 术后48小时累积阿片需求量三组分别为86±71、68±46和59±39,P<0.005(组3与组1比较)。
临床怎么用
- 对于全膝关节置换术患者,在局部浸润镇痛基础上联合收肌管阻滞和100μg鞘内吗啡可改善术后48小时内镇痛并减少阿片需求。
- 该联合方案未显示对术后第2天计时起立行走测试或3个月功能结局的益处。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Effective postoperative analgesia may enhance early rehabilitation after orthopedic surgery. This randomized double-blind trial investigates the relative contributions of adductor canal block and low-dose intrathecal morphine (ITM) to postoperative analgesia and functional recovery after total knee arthroplasty. METHODS: Two-hundred one patients undergoing elective unilateral total knee arthroplasty under spinal anesthesia were randomized to 3 groups. All patients received standardized intraoperative local infiltration analgesia and postoperative oral analgesics. Patients in group 1 received a "sham" adductor canal block with 30 mL of normal saline. Patients in group 2 received an adductor canal block with 30 mL of ropivacaine 0.5% with 1:400,000 epinephrine, whereas patients in group 3 received the adductor canal block with the active drug and 100 μg of ITM. The primary outcome measure was the Timed Up and Go (TUG) test on the second postoperative day. Secondary outcomes included postoperative pain scores and opioid requirements, distance walked, time to hospital discharge, and self-reported functional outcomes at 3 months. RESULTS: All 3 groups had similar values of TUG test on postoperative day (POD) 2 (46 [36-62], 45 [33-61], and 52 [41-69]; P = 0.166) as well as other short-term and 3-month functional outcomes. Patients in group 3 showed a favorable analgesic profile as evidenced by 3 positive secondary outcomes. These positive outcomes were lower pain scores 12 hours postoperatively both at rest (4 [2-6.3], 4 [2.3-6], and 3 [1-4]; P = 0.007) and on movement (6 [4-8], 6 [3-8], and 4 [2-6]; P = 0.002), a lower incidence of "rescue" intravenous patient-controlled analgesia (42%, 34%, and 20%; P = 0.031), and the lowest cumulative opioid requirements for the first 48 hours postoperatively (86 ± 71, 68 ± 46, and 59 ± 39; P < 0.005, group 3 compared with group 1). CONCLUSIONS: Our data suggest that there is no difference in either the primary outcome of TUG test on POD 2, other immediate functional secondary outcomes, or in global functional outcome at 3 months postoperatively across all 3 groups. Our data also suggest an improved analgesic profile in the first 48 hours postoperatively when both adductor canal block and low-dose ITM (100 μg) are added to local infiltration analgesia as evidenced by several positive secondary outcomes of lower pain scores and opioid requirements. CLINICAL TRIAL REGISTRATION: This study was registered at ClinicalTrials.gov, identifier NCT02411149.
引用
- Biswas A, Perlas A, Ghosh M, et al. Relative Contributions of Adductor Canal Block and Intrathecal Morphine to Analgesia and Functional Recovery After Total Knee Arthroplasty: A Randomized Controlled Trial. Reg Anesth Pain Med. 2018. PMID: 29315129. doi:10.1097/AAP.0000000000000724
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。